2021 Hospice In-home health Medicare 
Hospice News
JUNE 29, 2022
Congressional legislators are casting doubts on regulatory oversight of Medicare Advantage plans over concerns about spending, claims denials, and end-of-life care. Department of Health & Human Services Office of the Inspector General (OIG), the Medicare Payment Advisory Commission (MedPAC), and the Government Accountability Office.
Hospice News
MARCH 26, 2024
Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of home health companies among buyers. After 2023’s slump, PE firms have been sitting on more than $800 million in dry powder, according to data shared with Hospice News by The Braff Group. But additional data point to a resurgence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
NOVEMBER 1, 2023
NASDAQ: PNTG) has acquired Guardian Hospice and Guardian Hospice of Oklahoma for an undisclosed amount. Guardian Hospice of Oklahoma received Medicare certification in 2015 and has since grown its presence in the state and across Texas. Centers for Medicare & Medicaid Services (CMS). The Pennant Group Inc.
Hospice News
AUGUST 8, 2023
Hospices seeking to gauge the potential impact of new regulatory actions in the space can look to their counterparts in the home health field. We then started seeing the greater degree of impact,” Dombi told Hospice News. CMS is no doubt hoping for similar results for the Medicare Hospice Benefit.
Hospice News
SEPTEMBER 19, 2022
While hospice and home health M&A continue to burgeon, non-medical home care is starting to slip out from under their shadows. Deal volume for non-medical home care companies outstripped that for hospice or home health during the first half of the year. Hospice market to stay mighty.
Hospice News
JUNE 8, 2023
s (NYSE: EHAB) M&A journey has narrowed towards hospice, diverting less in home health’s direction. Reimbursement uncertainties, shrinking pools of available assets, and rising valuations in the home health space are forces steering the company’s sights towards hospice, according to Enhabit executives.
Hospice News
NOVEMBER 1, 2022
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.
Expert insights. Personalized for you.
211 
Let's personalize your content